I agree that the underwriter could look everything over closely and determine that the market is dead wrong in its valuation of NFUSZ.
OTC prices of pre-revenue companies are notorious for being all over the map - because they involve a lot of uninformed speculation and emotion, and because of the types of investors and perhaps the types of market marker algorithms that are employed.
For that reason, it is possible that the underwriter crunches the numbers but with a more much intelligent, structured, and analytical approach, and ends up valuing the stock far higher. Maybe an underwriter would find that Rory's belief that the price is severely undervalued is far closer to the truth than this market believes. In such a case the market would then tend to bid the price up to be a lot closer to the underwriter's valuation price - much like with a credible research report at higher prices, or with a buyout offer at a higher price.
Has that ever been done before with an OTC stock? I would think that IF it could be done, it has been done and there should be examples of it.
But, maybe this situation is just too unique to expect that we can find that kind of example.
Market Data 
Markets 
AI
